
Polyplus Concentrates Private Limited
About Polyplus Concentrates Private Limited
Data last updated:
Polyplus Concentrates Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 January 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U25209MH2009PTC189816. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Siddharth Somani and Gautam Shreeprakash Somani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 158/164 Kalbadevi R Oad 4th Floor Laxmi Bhawan, Mumbai, Maharashtra, India – 400002.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Polyplus Concentrates Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address158/164 Kalbadevi R Oad 4th Floor Laxmi Bhawan, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Polyplus Concentrates Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Polyplus Concentrates Private Limited
FY 2025 filings availablePolyplus Concentrates Private Limited reported revenue of ₹8,735 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Polyplus Concentrates Private Limited, buy the company report.
Board of directors of Polyplus Concentrates Private Limited
Polyplus Concentrates has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Somani | Director | 22 Jan 2009 | 17 Years 9 Months | Current |
| Gautam Shreeprakash Somani Also directs: G.S. Mining Company Private Limited, Everplus Plastics Private Limited, Swastik Capital and Stock Private Limited and 1 more | Director | 22 Jan 2009 | 17 Years 9 Months | Current |
Peer comparison
Polyplus Concentrates Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aventura Healthcare Private Limited | ₹8,840 (FY 2024) | 5.0% | Ambala Cantt, Haryana, India | |||
| Aum Mediaid Private Limited | ₹8,834 (FY 2024) | -86.0% | New Delhi, Delhi, India | |||
| Pulse Plus Private Limited | ₹8,747 (FY 2023) | -79.0% | Coimbatore, Tamil Nadu, India | |||
| Polyplus Concentrates Private Limitedthis company | ₹8,735 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Medicode Pharmaceuticals Private Limited | ₹8,619 (FY 2021) | Hyderabad, Telangana, India | ||||
| Genx Pharma Private Limited | ₹8,328 (FY 2025) | Hyderabad, Telangana, India |
To see the full peer comparison of Polyplus Concentrates Private Limited, buy the company report.
Auditor
Polyplus Concentrates Private Limited is audited by CHETANSTAK& CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHETANSTAK& CO | FY 2023 | 134769W |
Shareholding
The shareholding of Polyplus Concentrates Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Polyplus Concentrates Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Polyplus Concentrates Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Polyplus Concentrates Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Polyplus Concentrates has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Polyplus Concentrates Private Limited, buy the company report.
Recent activity
Polyplus Concentrates Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Manish Mahendra Somani ceased to be Director on 10 May 2022.
Frequently asked questions
Polyplus Concentrates is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 January 2009 (17+ years old) and is registered under CIN U25209MH2009PTC189816.
Polyplus Concentrates has 2 current directors:
- Siddharth Somani - Director
- Gautam Shreeprakash Somani - Director
The latest financial statements of Polyplus Concentrates on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Polyplus Concentrates has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Polyplus Concentrates is U25209MH2009PTC189816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Polyplus Concentrates was incorporated on 22 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Polyplus Concentrates by revenue are Aventura Healthcare Private Limited, Aum Mediaid Private Limited, Pulse Plus Private Limited, Medicode Pharmaceuticals Private Limited, Genx Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manish Mahendra Somani ceased to be Director on 10 May 2022. Gautam Shreeprakash Somani was appointed as Director on 22 Jan 2009. Siddharth Somani was appointed as Director on 22 Jan 2009.
The registered office of Polyplus Concentrates is at 158164 Kalbadevi R Oad 4th Floor Laxmi Bhawan, Mumbai, Maharashtra, India – 400002.
Polyplus Concentrates operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Polyplus Concentrates is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.

